Blood Content in Ehrlich Ascites Carcinoma Mice
Author Information
Author(s): F. Hartveit
Primary Institution: University of Bergen, School of Medicine
Hypothesis
The differences in survival time and blood content in mice injected with Ehrlich's ascites carcinoma may be influenced by genetic factors and treatments that reduce resistance to the tumor.
Conclusion
The blood content of the tumor ascites is an expression of the mouse's resistance to the tumor, with treated mice showing less blood and longer survival times.
Supporting Evidence
- The mean survival time was shortest in the control group and longest in the cortisone treated group.
- Blood content was highest in the control group and lowest in the cortisone treated group.
- Trypan blue treatment did not affect survival time but reduced blood content.
Takeaway
Mice with more blood in their tumors died faster, while those with less blood lived longer, suggesting that blood content shows how well the mice can fight the tumor.
Methodology
Three groups of 30 heterozygous mice were injected with Ehrlich's ascites carcinoma, with two groups receiving treatments to reduce their natural resistance.
Limitations
The study only used one type of tumor and a specific strain of mice, which may limit the generalizability of the findings.
Participant Demographics
Adult heterozygous mice, under 6 months old, from a closed colony.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website